Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.39 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.39 |
| ▸ | PPARG | P37231 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | RXRA | P19793 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
| ▸ | F7 | P08709 | 3/20 | 0.37 |
| ▸ | F3 | P13726 | 3/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.37 |
| ▸ | PPARA | Q07869 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | PPARD | Q03181 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6474724 | 0.88 | — | — | |
| SCHEMBL1325015 | 0.88 | — | — | |
| SCHEMBL6473577 | 0.88 | — | — | |
| SCHEMBL6473956 | 0.88 | — | — | |
| SCHEMBL19293246 | 0.88 | ALDH1A1 (0.48) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL23143217 | 0.88 | ALDH1A1 (0.48) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL1325012 | 0.88 | — | — | |
| SCHEMBL20834321 | 0.88 | ALDH1A1 (0.48) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL20530376 | 0.88 | ALDH1A1 (0.48) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL1199081 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230130617-A1 | PROCESS FOR IMPROVED OPIOID SYNTHESIS | RHODES TECHNOLOGIES (US) | 2023-04-27 | — | — | US | disclosed |
| US-10316042-B2 | Process for improved opioid synthesis | RHODES TECHNOLOGIES (US) | 2019-06-11 | — | — | US | disclosed |
| EP-2872516-B1 | PROCESS FOR IMPROVED OPIOID SYNTHESIS | RHODES TECH (US) | 2017-08-30 | — | — | EP | disclosed |
| US-20150315203-A1 | PROCESS FOR IMPROVED OPIOID SYNTHESIS | RHODES TECHNOLOGIES | 2015-11-05 | — | — | US | disclosed |
| EP-2872516-A1 | PROCESS FOR IMPROVED OPIOID SYNTHESIS | Rhodes Technologies (US) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014013313-A1 | PROCESS FOR IMPROVED OPIOID SYNTHESIS | RHODES TECHNOLOGIES (US) | 2014-01-23 | — | — | WO | disclosed |
| EP-1732929-B1 | TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS | NISSAN CHEMICAL IND LTD (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20080275066-A1 | Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists | NOVO NORDISK A/S (DK) | 2008-11-06 | — | — | US | disclosed |
| EP-1756135-A1 | ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS | GlaxoSmithKline istrazivacki centar Zagreb d.o.o. (HR) | 2007-02-28 | — | — | EP | disclosed |
| US-20060155150-A1 | Methods for the synthesis of lutein | CARDAX PHARMACEUTICALS, INC. | 2006-07-13 | — | — | US | disclosed |
| WO-2005108412-A1 | ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS | GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (US) | 2005-11-17 | — | — | WO | disclosed |
| US-20020042434-A1 | PHARMACEUTICAL COMPOSITION | TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) | 2002-04-11 | — | — | US | disclosed |
| US-5739140-A | AGRICULTURAL FUNGICIDES | MONSANTO COMPANY (US) | 1998-04-14 | — | — | US | disclosed |
| US-5015737-A | Antibiotics, bactericides | THE UPJOHN COMPANY (US) | 1991-05-14 | — | — | US | disclosed |
| US-4847259-A | Nitrogen-containing heterocyclic compounds, and use as insecticide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150315203-A1 | PROCESS FOR IMPROVED OPIOID SYNTHESIS | OPRK1, OPRM1, OPRD1 | ALDH1A1 1637/4885CYP19A1 703/4885OXER1 57/4885 |
| US-20060155150-A1 | Methods for the synthesis of lutein | LSS, DHPS, CYP51A1 | ALDH1A1 442/4885CYP19A1 15/4885OXER1 69/4885 |
| US-20080275066-A1 | Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists | GLP1R, GIPR, GCGR | ALDH1A1 2002/4885CYP19A1 540/4885OXER1 341/4885 |
| US-20020042434-A1 | PHARMACEUTICAL COMPOSITION | GPR119, IAPP, INSR | ALDH1A1 2114/4885CYP19A1 358/4885OXER1 2395/4885 |
| US-10316042-B2 | Process for improved opioid synthesis | OPRK1, OPRM1, OPRD1 | ALDH1A1 1637/4885CYP19A1 703/4885OXER1 57/4885 |
| US-20230130617-A1 | PROCESS FOR IMPROVED OPIOID SYNTHESIS | OPRK1, OPRM1, OPRD1 | ALDH1A1 1749/4885CYP19A1 747/4885OXER1 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.